Prognostic Value of Nivolumab Clearance in Non-Small Cell Lung Cancer Patients for Survival Early in Treatment

Otten, LS; Piet, B; van den Haak, D; Schouten, RD; Schuurbiers, M; Badrising, SK; Boerrigter, E; Burgers, SA; ter Heine, R; van den Heuvel, MM

Otten, LS (通讯作者),Radboud Univ Nijmegen, Dept Pharm, Med Ctr, POB 9101, NL-6500 HB Nijmegen, Netherlands.

CLINICAL PHARMACOKINETICS, 2023; 62 (12): 1749

Abstract

Introduction Immune checkpoint inhibitors improved survival of advanced stage non-small cell lung cancer patients, but the overall response rate remai......

Full Text Link